Subscribe To
Skye bioscience receives us fda authorization of investigational new drug application for sbi-100 oe
Skye Bioscience Inc (OTCQB:SKYE) said the US Food and Drug Administration (FDA) has authorized it to proceed with the Investigational New Drug (IND) ...
December 20, 2022, 7:53 am
Madrigal pharmaceuticals shares soar on positive trial results for its nash and liver fibrosis drug resmetirom
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares have soared more than 250% after the biopharmaceutical company shared positive topline results from ...
December 19, 2022, 10:41 am
Viking therapeutics' stock rallies after madrigal shares positive data about its liver drug
Shares of Viking Therapeutics Inc. VKTX, +4.42% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid ...
December 19, 2022, 8:42 am
Poolbeg pharma targets first half of next year for first trial of oral diabetes/anti-obesity drug
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has exclusively licensed specialist microencapsulation or nanoencapsulation developed by a company...
December 14, 2022, 2:40 am
Pharvaris shares soar on positive top-line phase 2 data from rapide-1 study as it releases 3q results
Pharvaris (NASDAQ:PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagon...
December 8, 2022, 11:34 am
Context therapeutics reports encouraging preliminary phase 2 data for ona-xr in metastatic breast cancer
Context Therapeutics (NASDAQ:CNTX) has announced preliminary Phase 2 data from the ongoing SMILE trial of onapristone extended-release (ONA-XR), the c...
December 8, 2022, 8:38 am
Algernon pharmaceuticals says ifenprodil granted orphan drug designation by us fda for treatment of ipf
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Ifenp...
December 5, 2022, 7:57 am
Pop biotechnologies’ snap vaccine system safe and effective in a phase ii clinical trial for covid-19
Featured Image for POP Biotechnologies Featured Image for POP Biotechnologies BUFFALO, N.Y., Nov. 30, 2022 (GLOBE NEWSWIRE) — POP Biotechnologies (P...
November 30, 2022, 8:01 pm
Astrazeneca (azn) boosts cell therapies with neogene deal
The acquisition of Neogene is set to give AstraZeneca (AZN) access to the latter's next-generation T-cell rece...
November 30, 2022, 9:47 am
Astrazeneca adds focus on personalised cancer cell therapy with us$320mln acquisition
AstraZeneca PLC (LSE:AZN) will spend up to US$320mln to strengthen its cancer business with an acquisition specialising in an innovative cell therapy ...
November 29, 2022, 3:35 am
Legend biotech set for clinical development of potential treatment for small cell lung cancer after fda approval
Legend Biotech Corporation (NASDAQ:LEGN) told investors that the US regulator, the Food and Drug Administration (FDA), had green-lighted its investiga...
November 21, 2022, 10:08 am
Adicet bio to present at upcoming investor conferences
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing fir...
September 7, 2022, 4:10 pm
Adicet bio to present at upcoming investor conferences
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing fir...
August 1, 2022, 4:10 pm
Celyad oncology to announce first half 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium, July 28, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...
July 28, 2022, 1:05 am
Celyad oncology to announce first half 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD)...
July 28, 2022, 1:00 am
Cytomx's breast cancer candidate meets primary goal of objective response rate
CytomX Therapeutics Inc's (NASDAQ: CTMX) Phase 2 study of praluzatamab ravtansine in hormone receptor-...
July 7, 2022, 6:32 am
Avalon globocare reveals new study using ai-powered protein design technology targeting glucose transporter against cancer
Avalon GloboCare Corp (NASDAQ:AVCO) announced a new study incorporating artificial intelligence (AI)-enhanced protein design technology that could acc...
June 30, 2022, 9:59 am
Immunogen: possible accelerated fda approval for ovarian cancer treatment
PDUFA date with Priority Review for mirvetuximab for treatment of ovarian cancer patients with high folate rec...
June 20, 2022, 2:51 pm
Avalon globocare to team up with lu daopei hematology institute to develop companion diagnostics for car-t cancer treatments
Avalon GloboCare Corp (NASDAQ:AVCO) has signed a memorandum of understanding with Lu Daopei Hematology Institute (LDHI) to co-develop precision compan...
May 18, 2022, 10:53 am
Celyad oncology to present at the h.c. wainwright global investment conference
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biote...
May 17, 2022, 4:05 pm